Mediwound Ltd

MDWD03 Dec 2024
Healthcare
$17.57
+0.03 (+3.43%)
Lowest Today
$17.57
Highest Today
$18.26
Today’s Open
$17.57
Prev. Close
$17.47
52 Week High
$24
52 Week Low
$8.81
To Invest in Mediwound Ltd

Mediwound Ltd

Healthcare
MDWD03 Dec 2024
+0.03 (+3.43%)
1M
3M
6M
1Y
5Y
Low
$17.57
Day’s Range
High
$18.26
17.57
52 Week Low
$8.81
52-Week Range
52 Week High
$24
8.81
1 Day
-
1 Week
+4.34%
1 month return
-1.89%
3 month return
-2.42%
6 month return
+8.85%
1 Year return
+103.23%
3 Years return
-1.73%
5 Years return
-14.83%
10 Years return
-
Institutional Holdings
Investors Finance Co PLC
8.09
Rosalind Advisors, Inc.
5.82
BlackRock Inc
3.6
Yelin Lapidot Holdings Management Ltd
2.67
iShares Russell 2000 ETF
1.91
Balyasny Asset Management LLC
1.54
Wells Fargo & Co
1.22

Market Status

Fundamentals
Market Cap
188.29 mln
PB Ratio
5.5
PE Ratio
0
Enterprise Value
149.18 mln
Total Assets
66.46 mln
Volume

Company Financials

Fund house & investment objective

Company Information
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Organisation
Mediwound Ltd
Employees
100
Industry
Biotechnology
CEO
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities